FIXED DOSE COMBINATION (FDC) OF INDACATEROL ACETATE (IND) AND MOMETASONE FUROATE (MF) AS A MAINTENANCE TREATMENT OF ASTHMA IN PATIENTS NOT ADEQUATELY CONTROLLED WITH INHALED CORTICOSTEROIDS AND INHALED SHORT ACTING BETA2-AGONISTS: A BUDGET IMPACT ANALISYS IN ITALY

被引:0
|
作者
Mangia, P. P. [1 ]
Pradelli, L. [1 ]
Gallo, O. [2 ]
Ritrovato, D. [2 ]
Ting, B. [3 ]
机构
[1] AdRes HEOR, Turin, TO, Italy
[2] Novartis Farma Italy, Origgio, Italy
[3] Novartis Corp Sdn Bhd, Petaling Jaya, Malaysia
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRS39
引用
收藏
页码:S724 / S724
页数:1
相关论文
共 11 条
  • [11] A Randomized Controlled Trial of Electronic Medication Monitoring (EMM), Patient Mobile App and Health Care Provider Feedback compared to EMM alone on Inhaled Corticosteroids (ICS) and Short Acting Beta2 Agonists (SABA) Utilization and Asthma Control in Adult Patients with Uncontrolled Asthma
    Mosnaim, Giselle
    Gonzalez, Candy
    Adams, Brittney
    Zhu, Linda
    Quan, Priscillia
    Olive, Naomi BenIsrael
    Shalowitz, Madeleine
    Gondalia, Rahul
    Kaye, Leanne
    Stempel, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB58 - AB58